Detalles de la búsqueda
1.
Consensus statements and treatment algorithm to guide clinicians in the selection of maintenance therapy for patients with newly diagnosed, advanced ovarian carcinoma: Results of a Delphi study.
Gynecol Oncol
; 175: 182-189, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37355448
2.
Low and Ultra-Low HER2 in Human Breast Cancer: An Effort to Define New Neoplastic Subtypes.
Int J Mol Sci
; 24(16)2023 Aug 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37628975
3.
Efficacy of T-DM1 for leptomeningeal and brain metastases in a HER2 positive metastatic breast cancer patient: new directions for systemic therapy - a case report and literature review.
BMC Cancer
; 18(1): 97, 2018 01 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-29370839
4.
The risk of toxicities from trastuzumab, alone or in combination, in an elderly breast cancer population.
Oncology
; 86(1): 16-21, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24335608
5.
Uncommon breast metastatic site and eribulin responsiveness in a heavily pretreated patient.
Future Oncol
; 10(15): 2417-22, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25525850
6.
Therapeutic efficacy of platinum/etoposide regimens in the treatment of advanced poorly differentiated neuroendocrine carcinomas of the lung: A retrospective analysis.
Front Endocrinol (Lausanne)
; 14: 1065599, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36793289
7.
Correction: The prognostic significance of combined androgen receptor, E-Cadherin, Ki67 and CK5/6 expression in patients with triple negative breast cancer.
Oncotarget
; 10(8): 917, 2019 01 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-30783520
8.
Eribulin mesylate use as third-line therapy in patients with metastatic breast cancer (VESPRY): a prospective, multicentre, observational study.
Ther Adv Med Oncol
; 11: 1758835919895755, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31903098
9.
Influence of EGFR mutational status on metastatic behavior in non squamous non small cell lung cancer.
Oncotarget
; 8(5): 8717-8725, 2017 Jan 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-28060728
10.
Emerging role of Radium-223 in the growing therapeutic armamentarium of metastatic castration-resistant prostate cancer.
Expert Opin Pharmacother
; 18(9): 899-908, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28449621
11.
The prognostic significance of combined androgen receptor, E-Cadherin, Ki67 and CK5/6 expression in patients with triple negative breast cancer.
Oncotarget
; 8(44): 76974-76986, 2017 09 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-29100362
12.
Nab-paclitaxel and trastuzumab combination: a promising approach for neoadjuvant treatment in HER2-positive breast cancer.
Onco Targets Ther
; 9: 4351-5, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27499629
13.
Central nervous system involvement in ALK-rearranged NSCLC: promising strategies to overcome crizotinib resistance.
Expert Rev Anticancer Ther
; 16(6): 615-23, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-27109446
14.
Efficacy of nab-paclitaxel plus trastuzumab in a long-surviving heavily pretreated HER2-positive breast cancer patient with brain metastases.
Onco Targets Ther
; 8: 289-94, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25678799
15.
A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): Old successes and future perspectives.
Oncotarget
; 6(29): 26814-25, 2015 Sep 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-26308162
16.
Androgen Receptor (AR), E-Cadherin, and Ki-67 as Emerging Targets and Novel Prognostic Markers in Triple-Negative Breast Cancer (TNBC) Patients.
PLoS One
; 10(6): e0128368, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26039245
17.
NSCLC and HER2: between lights and shadows.
J Thorac Oncol
; 9(12): 1750-62, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25247338
18.
Rapid Acquisition of T790M Mutation after Treatment with Afatinib in an NSCLC Patient Harboring EGFR Exon 20 S768I Mutation.
J Thorac Oncol
; 12(1): e6-e8, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27988103
19.
Prognostic value of androgen receptor expression in triple negative breast carcinomas: personal experience and comments on a review about "Triple-negative breast cancer: treatment challenges and solutions" by Collignon et al.
Breast Cancer (Dove Med Press)
; 8: 157-9, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27578997
20.
Correction: Androgen Receptor (AR), E-Cadherin, and Ki-67 as Emerging Targets and Novel Prognostic Markers in Triple-Negative Breast Cancer (TNBC) Patients.
PLoS One
; 10(7): e0132647, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26135303
Resultados
1 -
20
de 20
1
Próxima >
>>